Literature DB >> 3941454

The ultrastructure of the erectile tissue in priapism.

M A Spycher, D Hauri.   

Abstract

The ultrastructure of erectile tissue from the corpora cavernosa penis of patients suffering from stasis priapism and high-flow priapism has been studied. Trabecular interstitial edema was confirmed as the first reaction of the tissue to the hemodynamic impairment. At the cellular level trabecular smooth muscle cells were found to be the first affected by the altered environmental conditions. Their reaction consisted of structural and functional transformation to fibroblast-like cells. Severe cellular damage and widespread necrosis were not seen in high flow priapism; such damage existed in stasis priapism, but only when the priapic episode lasted more than 24 hours. Blood clot formation within the cavernae and destruction of the endothelial lining occurred in stasis priapism lasting over 48 hours. At this time trabecular inflammation became conspicuous and most of the smooth muscle cells were either transformed to fibroblast-like cells or had undergone necrosis. This stage was not reached in high flow priapism, a fact supporting the view that high flow priapism is a more benign and prognostically more favorable form of priapism. Massive smooth muscle cell transformation and the loss of contractile trabecular elements may play an important role in the evolution of irreversible erectile failure following stasis priapism persisting longer than 24 hours.

Entities:  

Mesh:

Year:  1986        PMID: 3941454     DOI: 10.1016/s0022-5347(17)45549-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  45 in total

1.  The effects of oxytocin on penile tissues in experimental priapism model in rats.

Authors:  Engin Kolukcu; Sahin Kilic; Bekir Suha Parlaktas; Fikret Erdemir; Velid Unsal; Dogan Atılgan; Nihat Uluocak
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

Review 2.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 3.  Stuttering priapism: insights into pathogenesis and management.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

4.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

5.  Postoperative drug-induced priapism.

Authors:  Bartholomeus J G A Corten; Frits Aarts; Ansgar S Harms; Jeroen Vogelaar
Journal:  BMJ Case Rep       Date:  2017-05-31

6.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

7.  Management of priapism in adult men.

Authors:  Onyeanunam N Ekeke; Hannah E Omunakwe; Ndu Eke
Journal:  Int Surg       Date:  2015-03

8.  Pharmacological priapism: comparison of trazodone- and papaverine-associated cases.

Authors:  E D Bardin; J N Krieger
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

9.  A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction.

Authors:  George F Lasker; Jason H Maley; Philip J Kadowitz
Journal:  Adv Pharmacol Sci       Date:  2010

Review 10.  Priapism: pathophysiology and the role of the radiologist.

Authors:  J E Halls; D V Patel; M Walkden; U Patel
Journal:  Br J Radiol       Date:  2012-09-06       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.